A biochemist from Monash University with a background in synthetic biology, Priya previously managed R&D partnerships at a contract research organisation. She saw an opportunity to apply CRISPR applications to rare genetic disorders and launched her biotech startup in 2021. Her work has attracted interest from major pharmaceutical companies.